BRIEF-Telesta Therapeutics posts Q3 net loss of $1.6 mln vs $3.3 mln in 2015
May 10 (Reuters) - Telesta Therapeutics Inc :
* Telesta Therapeutics publishes its Q3, 2016 financial statements and provides corporate updates
* Qtrly net loss $1.6 million, compared to a net loss for comparable period ending March 31, 2015 of $3.3 million
* Company continues to identify and implement opportunities to reduce ongoing operating expenditures
* Board actively evaluating opportunities to create shareholder value, through execution of one or more strategic options
* Strategic options include sale of co, acquisition of development-stage or commercial assets, merger of co with another biotechnology co Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.